SG143252A1 - Polymer derivatives - Google Patents

Polymer derivatives

Info

Publication number
SG143252A1
SG143252A1 SG200803528-9A SG2008035289A SG143252A1 SG 143252 A1 SG143252 A1 SG 143252A1 SG 2008035289 A SG2008035289 A SG 2008035289A SG 143252 A1 SG143252 A1 SG 143252A1
Authority
SG
Singapore
Prior art keywords
amino acids
proteins
polymer
derivatives
azide
Prior art date
Application number
SG200803528-9A
Other languages
English (en)
Inventor
Troy E Wilson
Original Assignee
Ambrx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambrx Inc filed Critical Ambrx Inc
Publication of SG143252A1 publication Critical patent/SG143252A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/321—Polymers modified by chemical after-treatment with inorganic compounds
    • C08G65/325—Polymers modified by chemical after-treatment with inorganic compounds containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F216/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical
    • C08F216/12—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical by an ether radical
    • C08F216/14—Monomers containing only one unsaturated aliphatic radical
    • C08F216/16—Monomers containing no hetero atoms other than the ether oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/02—Alkylation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Polyethers (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG200803528-9A 2003-10-09 2004-10-07 Polymer derivatives SG143252A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51016903P 2003-10-09 2003-10-09

Publications (1)

Publication Number Publication Date
SG143252A1 true SG143252A1 (en) 2008-06-27

Family

ID=34435064

Family Applications (2)

Application Number Title Priority Date Filing Date
SG200803528-9A SG143252A1 (en) 2003-10-09 2004-10-07 Polymer derivatives
SG2011081239A SG176455A1 (en) 2003-10-09 2004-10-07 Polymer derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2011081239A SG176455A1 (en) 2003-10-09 2004-10-07 Polymer derivatives

Country Status (6)

Country Link
US (5) US7230068B2 (fr)
EP (2) EP2322569B1 (fr)
JP (3) JP4890253B2 (fr)
ES (2) ES2831379T3 (fr)
SG (2) SG143252A1 (fr)
WO (1) WO2005035727A2 (fr)

Families Citing this family (136)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG143252A1 (en) * 2003-10-09 2008-06-27 Ambrx Inc Polymer derivatives
JP4896745B2 (ja) 2004-02-02 2012-03-14 アンブレツクス・インコーポレイテツド 修飾されたヒトインターフェロンポリペプチドおよびこれらの使用
AU2005265163B2 (en) 2004-06-18 2009-10-01 Ambrx, Inc. Novel antigen-binding polypeptides and their uses
MX2007000728A (es) * 2004-07-21 2007-03-15 Ambrx Inc Polipeptidos biosinteticos que utilizan amino acidos no naturalmente codificados.
CA2584510C (fr) 2004-10-25 2013-05-28 Intezyne Technologies, Incorporated Poly(ethyleneglycol) heterobifonctionnel et utilisations associees
EP2325206B1 (fr) 2004-11-12 2014-03-19 Xencor, Inc. Variants de fc avec une liaison altérée à fcrn
US8802820B2 (en) 2004-11-12 2014-08-12 Xencor, Inc. Fc variants with altered binding to FcRn
US8080391B2 (en) 2004-12-22 2011-12-20 Ambrx, Inc. Process of producing non-naturally encoded amino acid containing high conjugated to a water soluble polymer
US7816320B2 (en) 2004-12-22 2010-10-19 Ambrx, Inc. Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
CN101087875B (zh) 2004-12-22 2012-08-22 Ambrx公司 氨酰基-tRNA合成酶的组合物及其用途
CN103690936A (zh) * 2004-12-22 2014-04-02 Ambrx公司 经修饰的人类生长激素
US8067006B2 (en) * 2005-04-06 2011-11-29 Immunomedics, Inc. Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
SG165353A1 (en) 2005-06-03 2010-10-28 Ambrx Inc Improved human interferon molecules and their uses
CA2615857A1 (fr) * 2005-07-18 2007-01-25 The Scripps Research Institute Procede de fabrication de dendrimeres amphiphiles
US7301003B2 (en) * 2005-08-26 2007-11-27 Enzon Pharmaceuticals, Inc. Method of preparing polymers having terminal amine groups
PT2339014E (pt) 2005-11-16 2015-10-13 Ambrx Inc Métodos e composições compreendendo aminoácidos não-naturais
WO2007104948A2 (fr) 2006-03-10 2007-09-20 Warwick Effect Polymers Ltd. Polymères
CA2861601A1 (fr) * 2006-04-27 2007-11-08 Intezyne Technologies, Inc. Poly(ethylene glycol) contenant des endogroupes chimiquement disparates
US20080096819A1 (en) * 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
WO2007130453A2 (fr) * 2006-05-02 2007-11-15 Allozyne, Inc. Molécules substituées par des acides aminés
US8242058B2 (en) * 2006-07-21 2012-08-14 Wisconsin Alumni Research Foundation Reagents and methods for appending functional groups to proteins
ES2465473T3 (es) 2006-09-08 2014-06-05 Ambrx, Inc. Transcripción de arnt supresor en células de vertebrado
JP5840345B2 (ja) 2006-09-08 2016-01-06 アンブルックス, インコーポレイテッドAmbrx, Inc. 修飾ヒト血漿ポリペプチドまたは修飾ヒトＦｃ足場タンパク質ならびにこれらの利用
JP5515224B2 (ja) 2007-02-28 2014-06-11 日油株式会社 多分岐鎖ポリオキシアルキレン誘導体
ATE554785T1 (de) 2007-03-30 2012-05-15 Ambrx Inc Modifizierte fgf-21 polypeptide und ihre verwendung
JP2010525821A (ja) * 2007-05-02 2010-07-29 アンブルックス，インコーポレイテッド 修飾ＩＦＮβポリペプチドおよびこれらの使用
US20090047517A1 (en) * 2007-06-27 2009-02-19 Francesco Caruso Multilayer polymer films
CA2707840A1 (fr) * 2007-08-20 2009-02-26 Allozyne, Inc. Molecules substituees par des acides amines
US10966431B2 (en) * 2007-09-11 2021-04-06 Freedom Towel Holdings, LLC. Refreshment towel and applied solution
US8182826B2 (en) * 2007-09-11 2012-05-22 Whitmire A Jeffrey Refreshment towel and applied solution
DK2217265T3 (en) 2007-11-20 2017-07-03 Ambrx Inc Modified insulin polypeptides and their use
US20110124841A1 (en) * 2007-12-13 2011-05-26 Monthony James F Polypeptides Modified by Protein Trans-Splicing Technology
CA3086659A1 (fr) 2007-12-26 2009-07-09 Xencor, Inc. Variants de fc avec une liaison alteree a fcrn
EP2247743B1 (fr) 2008-02-08 2016-04-06 Ambrx, Inc. Polypeptides leptine modifiés et leurs utilisations
BRPI0916515B8 (pt) 2008-07-23 2021-07-27 Ambrx Inc polipeptídeo de fator estimulante de colônias de granulócitos bovino (bg-csf), formulação farmacêutica e composição compreendendo o mesmo
EP2328620A2 (fr) * 2008-07-31 2011-06-08 Alma Mater Studiorum - Università di Bologna Particules actives destinées à des applications bio-analytiques et procédés de préparation de celles-ci
MX346001B (es) 2008-09-26 2017-03-01 Ambrx Inc Polipeptidos de eritropoyetina animal modificados y sus usos.
BRPI0919031A2 (pt) 2008-09-26 2014-09-23 Ambrx Inc Micro-organismos e vacinas dependentes de replicação através do uso de aminoácidos não naturais
RU2536937C2 (ru) 2008-10-14 2014-12-27 Дженентек, Инк. Варианты иммуноглобулина и их применения
KR20110091720A (ko) * 2008-11-04 2011-08-12 얀센 파마슈티카 엔.브이. Ｃｒｈｒ2 펩티드 작용제 및 이의 용도
EP2191887A1 (fr) * 2008-11-26 2010-06-02 Polymers CRC Limited Membranes de polyamide à film mince cliquables
BRPI0918204A2 (pt) 2008-12-23 2015-12-08 Genentech Inc igv variante composição farmaceutica e kit
US9238878B2 (en) 2009-02-17 2016-01-19 Redwood Bioscience, Inc. Aldehyde-tagged protein-based drug carriers and methods of use
BRPI1010297A2 (pt) 2009-04-07 2017-06-06 Roche Glycart Ag anticorpos biespecíficos trivalentes.
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
BR112012005893A2 (pt) 2009-09-16 2016-11-22 Genentech Inc hélice enrolada e/ou complexos de proteínas contendo conectores e usos dos mesmos
WO2011057027A2 (fr) * 2009-11-04 2011-05-12 Janssen Pharmaceutica Nv Méthode de traitement de l'insuffisance cardiaque avec des peptides de type stresscopine
WO2011059994A2 (fr) * 2009-11-11 2011-05-19 3M Innovative Properties Company Compositions polymères et procédé de fabrication et articles de celles-ci
WO2011097527A2 (fr) 2010-02-04 2011-08-11 Xencor, Inc. Immunoprotection de fractions thérapeutiques avec des régions fc améliorées
WO2011113065A2 (fr) * 2010-03-12 2011-09-15 Intezyne Technologies, Incorporated Polyplexes pegylés pour l'administration de polynucléotides
AR080793A1 (es) 2010-03-26 2012-05-09 Roche Glycart Ag Anticuerpos biespecificos
EP4302783A3 (fr) 2010-08-17 2024-03-13 Ambrx, Inc. Polypeptides de relaxine modifiés et leurs utilisations
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
CA2807278A1 (fr) 2010-08-24 2012-03-01 F. Hoffmann - La Roche Ag Anticorps bispecifiques comprenant un fragment fv stabilise par bisulfure
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
WO2012085111A1 (fr) 2010-12-23 2012-06-28 F. Hoffmann-La Roche Ag Complexe polypeptide-polynucléotide et son utilisation dans l'administration d'une fraction effectrice ciblée
JP6162606B2 (ja) 2011-01-14 2017-07-12 レッドウッド バイオサイエンス， インコーポレイテッド アルデヒド−タグ付き免疫グロブリンポリペプチド及びその使用方法
KR101638224B1 (ko) 2011-02-28 2016-07-08 에프. 호프만-라 로슈 아게 항원 결합 단백질
EP2681240B1 (fr) 2011-02-28 2017-08-16 F. Hoffmann-La Roche AG Protéines monovalentes de liaison à l'antigène
HUE041335T2 (hu) 2011-03-29 2019-05-28 Roche Glycart Ag Antitest FC-variánsok
EP2812357B1 (fr) 2012-02-10 2020-11-04 F.Hoffmann-La Roche Ag Anticorps et autres hétéromultimères monocaténaires
NZ628126A (en) 2012-02-16 2016-10-28 Atyr Pharma Inc Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
US20140051834A1 (en) 2012-06-21 2014-02-20 Hoffmann-La Roche, Inc. Incretin Receptor Ligand Polypeptide Fc-Region Fusion Polypeptides And Conjugates With Altered Fc-Effector Function
CN104395339A (zh) 2012-06-27 2015-03-04 弗·哈夫曼-拉罗切有限公司 用于选择并产生含有至少两种不同结合实体的定制高度选择性和多特异性靶向实体的方法及其用途
CN104411718B (zh) 2012-06-27 2018-04-24 弗·哈夫曼-拉罗切有限公司 用于制备包含特异性结合靶的至少一种结合实体的抗体Fc区缀合物的方法及其用途
IN2014DN11157A (fr) 2012-07-13 2015-10-02 Roche Glycart Ag
WO2014078866A2 (fr) 2012-11-19 2014-05-22 Xencor, Inc. Immunoglobulines synthétiques ayant une demi-vie in vivo étendue
CA2906927C (fr) 2013-03-15 2021-07-13 Xencor, Inc. Modulation de cellules t avec des anticorps bispecifiques et des fusions de fc
WO2014145806A2 (fr) 2013-03-15 2014-09-18 Xencor, Inc. Protéines hétérodimériques
US9260527B2 (en) 2013-03-15 2016-02-16 Sdix, Llc Anti-human CXCR4 antibodies and methods of making same
CN105378075B (zh) 2013-03-15 2022-04-05 Atyr 医药公司 组氨酰-trna合成酶-fc缀合物
RU2019108429A (ru) 2013-04-29 2019-05-06 Ф. Хоффманн-Ля Рош Аг Модифицированные асимметричные антитела, связывающие fc-рецептор, и способы их применения
MX365787B (es) 2013-04-29 2019-06-14 Hoffmann La Roche Anticuerpos modificados de unión a receptor de fc neonatal (fcrn) humano y uso de los mismos.
EP3055329B1 (fr) 2013-10-11 2018-06-13 F. Hoffmann-La Roche AG Anticorps à chaîne variable légère commune échangés dans un domaine multispécifique
FR3013712B1 (fr) * 2013-11-22 2016-09-09 Herakles Polymeres a fonctions terminales azoture, leur obtention; propergols solides obtenus a partir desdits polymeres
US10137170B2 (en) 2013-12-20 2018-11-27 Indiana University Research And Technology Corporation Lipidated incretin receptor ligand human immunoglobulin Fc-region fusion polypeptides
EP3835318A1 (fr) 2014-01-15 2021-06-16 F. Hoffmann-La Roche AG Variants de région fc à fcrn modifié et propriétés de ligand a protéique maintenues
KR20230022270A (ko) 2014-03-28 2023-02-14 젠코어 인코포레이티드 Cd38 및 cd3에 결합하는 이중특이적 항체
PT3412302T (pt) 2014-10-24 2021-06-09 Bristol Myers Squibb Co Polipéptidos de fgf-21 modificados e utilizações dos mesmos
JP6576456B2 (ja) 2014-11-06 2019-09-18 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 修飾されたＦｃＲｎ結合特性およびプロテインＡ結合特性を有するＦｃ領域変種
ES2749383T3 (es) 2014-11-06 2020-03-20 Hoffmann La Roche Variantes de la región Fc con unión al FcRn modificada y procedimientos de uso
TN2017000222A1 (en) 2014-11-26 2018-10-19 Xencor Inc Heterodimeric antibodies that bind cd3 and cd38
AU2015353409B2 (en) 2014-11-26 2019-05-09 Xencor, Inc. Heterodimeric antibodies that bind CD3 and tumor antigens
US20160176969A1 (en) 2014-11-26 2016-06-23 Xencor, Inc. Heterodimeric antibodies including binding to cd8
EP3227332B1 (fr) 2014-12-03 2019-11-06 F.Hoffmann-La Roche Ag Anticorps multi-spécifiques
CA2969584C (fr) 2014-12-04 2023-03-14 Celgene Corporation Conjugues de biomolecule
WO2016141387A1 (fr) 2015-03-05 2016-09-09 Xencor, Inc. Modulation de lymphocytes t avec des anticorps bispécifiques et des hybrides fc
TN2017000470A1 (en) 2015-05-08 2019-04-12 Xencor Inc Heterodimeric antibodies that bind cd3 and tumor antigens.
CA2990305A1 (fr) 2015-06-26 2016-12-29 Mab Discovery Gmbh Anticorps monoclonaux anti-il-1racp
CN108350066B (zh) 2015-10-29 2022-04-15 豪夫迈·罗氏有限公司 抗变体Fc区抗体及使用方法
CN105330834B (zh) * 2015-10-29 2017-10-27 江苏中铁奥莱特新材料股份有限公司 一种侧链端基改性聚羧酸系抗泥减水剂的制备方法
EP3448885A4 (fr) 2016-04-26 2020-01-08 R.P. Scherer Technologies, LLC Conjugués d'anticorps et méthodes de fabrication et d'utilisation de ceux-ci
BR112018069890A2 (pt) 2016-05-02 2019-02-05 Hoffmann La Roche polipeptídio de fusão que se liga de forma específica a um alvo, polipeptídio de fusão dimérico, ácido nucleico isolado, par de ácidos nucleicos isolados, célula hospedeira, método para produzir um polipeptídio de fusão, imunoconjugado, formulação farmacêutica, polipeptídio de fusão e uso do polipeptídio de fusão
EP3241845A1 (fr) 2016-05-06 2017-11-08 MAB Discovery GmbH Anticorps anti-il-1r3 humanisés
EP3464365A1 (fr) 2016-06-01 2019-04-10 Xencor, Inc. Anticorps bispécifiques qui lient cd123 et cd3
EP3464370A1 (fr) 2016-06-01 2019-04-10 Xencor, Inc. Anticorps bispécifiques qui se lient à cd20 et cd3 destinés à être utilisés dans le traitement d'un lymphome
KR102450208B1 (ko) 2016-08-17 2022-10-05 컴퓨젠 엘티디. 항-tigit 항체, 항-pvrig 항체 및 이들의 조합
WO2018045110A1 (fr) 2016-08-30 2018-03-08 Xencor, Inc. Anticorps immunomodulateurs bispécifiques qui se lient à des récepteurs de costimulation et de points de contrôle
AU2017342560B2 (en) 2016-10-14 2022-03-17 Xencor, Inc. IL15/IL15Ralpha heterodimeric Fc-fusion proteins
EP3565833A1 (fr) 2017-01-09 2019-11-13 Torch Therapeutics Agents thérapeutiques bispécifiques conditionnellement efficaces
TW201837051A (zh) 2017-02-08 2018-10-16 美商必治妥美雅史谷比公司 包含藥物動力學增強劑之經修飾之鬆弛素(relaxin)多肽及其用途
EP3401332A1 (fr) 2017-05-08 2018-11-14 MAB Discovery GmbH Anticorps anti-il-1r3 destinés à être utilisés dans des conditions inflammatoires
WO2018223004A1 (fr) 2017-06-01 2018-12-06 Xencor, Inc. Anticorps bispécifiques se liant à cd20 et cd3
CA3064331A1 (fr) 2017-06-01 2018-12-06 Compugen Ltd. Therapies a base d'anticorps a triple combinaison
US20200181274A1 (en) 2017-06-01 2020-06-11 Novartis Ag Bispecific antibodies that bind cd 123 cd3
EP3645122A1 (fr) 2017-06-30 2020-05-06 Xencor, Inc. Protéines de fusion fc hétérodimères ciblées contenant il-15/il-15ra et domaines de liaison à l'antigène
JP2021500930A (ja) 2017-11-01 2021-01-14 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｃｏｍｐボディ−多価標的結合物質
KR20200100098A (ko) 2017-12-19 2020-08-25 젠코어 인코포레이티드 조작된 il-2 fc 융합 단백질
WO2019157340A1 (fr) 2018-02-08 2019-08-15 Amgen Inc. Formulation d'anticorps pharmaceutique à ph faible
AU2019256520A1 (en) 2018-04-18 2020-11-26 Xencor, Inc. LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and LAG-3 antigen binding domains
CA3097625A1 (fr) 2018-04-18 2019-10-24 Xencor, Inc. Proteines de fusion fc heterodimeres il-15/il-15ra et leurs utilisations
SG11202010163QA (en) 2018-04-18 2020-11-27 Xencor Inc Pd-1 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and pd-1 antigen binding domains and uses thereof
KR20210003814A (ko) 2018-04-18 2021-01-12 젠코어 인코포레이티드 IL-15/IL-15Rα Fc-융합 단백질 및 TIM-3 항원 결합 도메인을 함유하는 TIM-3 표적화 이종이량체 융합 단백질
AU2019260717A1 (en) 2018-04-27 2020-11-12 Novartis Ag Dosing of a bispecific antibody that bind CD123 and CD3
CN112512578A (zh) 2018-06-01 2021-03-16 诺华股份有限公司 结合cd123和cd3的双特异性抗体的给药
CA3101019A1 (fr) 2018-06-01 2019-12-05 Compugen Ltd Anticorps bispecifiques anti-pvrig/anti-tigit et procedes d'utilisation
EP3817770A2 (fr) 2018-07-02 2021-05-12 Amgen Inc. Protéine de liaison à l'antigène anti-steap1
TW202019965A (zh) 2018-07-16 2020-06-01 美商安進公司 治療多發性骨髓瘤之方法
WO2020066743A1 (fr) * 2018-09-28 2020-04-02 日本ゼオン株式会社 Composé de polyéther et membrane de séparation de gaz
KR20210091710A (ko) 2018-10-12 2021-07-22 젠코어 인코포레이티드 PD-1 표적화 IL-15/IL-15Rα Fc 융합 단백질 및 병용요법에서의 이의 용도
WO2020132646A1 (fr) 2018-12-20 2020-06-25 Xencor, Inc. PROTÉINES DE FUSION FC HÉTÉRODIMÈRES CIBLÉES CONTENANT LES IL-15/IL-15Rα ET DES DOMAINES DE LIAISON À L'ANTIGÈNE NKG2D
AU2020211407A1 (en) 2019-01-23 2021-08-12 Millennium Pharmaceuticals, Inc. Anti-CD38 antibodies
CN111849122B (zh) * 2019-04-25 2022-06-14 常熟生益科技有限公司 一种树脂组合物及其应用
TW202128757A (zh) 2019-10-11 2021-08-01 美商建南德克公司 具有改善之特性的 PD-1 標靶 IL-15/IL-15Rα FC 融合蛋白
WO2021113831A1 (fr) 2019-12-05 2021-06-10 Compugen Ltd. Anticorps anti-pvrig et anti-tigit pour élimination de tumeurs à base de cellules nk améliorées
US20230039818A1 (en) * 2020-01-08 2023-02-09 Zepto Life Technology, LLC Polymer compositions and biosurfaces comprising them on sensors
EP4096698A1 (fr) 2020-01-28 2022-12-07 Genentech, Inc. Protéines de fusion hétérodimères fc-il15/il15r alpha pour le traitement du cancer
WO2021171264A1 (fr) 2020-02-28 2021-09-02 Novartis Ag Dosage d'un anticorps bispécifique qui se lie à cd123 et cd3
US20240002509A1 (en) 2020-11-06 2024-01-04 Novartis Ag ANTIBODY Fc VARIANTS
CN114644708B (zh) 2020-12-18 2023-06-27 珠海泰诺麦博生物技术有限公司 呼吸道合胞病毒特异性结合分子
WO2022140701A1 (fr) 2020-12-24 2022-06-30 Xencor, Inc. Protéines de fusion hétérodimères ciblées par icos contenant des protéines de fusion fc d'il-15/il-15ra et domaines de liaison à l'antigène icos
WO2023010031A1 (fr) 2021-07-28 2023-02-02 Genentech, Inc. Protéines de fusion à fc hétérodimères il15/il15r alpha pour le traitement de cancers du sang
WO2023015198A1 (fr) 2021-08-04 2023-02-09 Genentech, Inc. Protéines de fusion hétérodimères avec fc et il15/il15r alpha servant à faire proliférer des lymphocytes nk dans le traitement de tumeurs solides
WO2023021055A1 (fr) 2021-08-19 2023-02-23 F. Hoffmann-La Roche Ag Anticorps à région fc anti-variant multivalente et méthode d'utilisation
WO2023175498A1 (fr) 2022-03-17 2023-09-21 Pfizer Inc. Enzymes de dégradation d'igg améliorées et leurs procédés d'utilisation
WO2023196905A1 (fr) 2022-04-07 2023-10-12 Xencor, Inc. Protéines de fusion hétérodimères ciblant lag-3 contenant des protéines de fusion fc d'il-15/il-15ra et domaines de liaison à l'antigène de lag-3

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1245943A (en) * 1968-08-08 1971-09-15 Ici Ltd Polyoxyalkylene derivatives
JPS5855830Y2 (ja) 1978-12-28 1983-12-21 富士通株式会社 電子装置の放熱構造
JPS5592000A (en) * 1978-12-29 1980-07-11 Chuo Kagaku Kk Electrolytic cleaning agent composition
US4289872A (en) * 1979-04-06 1981-09-15 Allied Corporation Macromolecular highly branched homogeneous compound based on lysine units
JPS6023761B2 (ja) * 1979-11-02 1985-06-10 積水化学工業株式会社 感光性重合体の製造方法
US5597978A (en) * 1984-12-27 1997-01-28 Aerojet-General Corporation High energy hydroxy-terminated polyazido polymers
SU1308594A1 (ru) * 1985-04-15 1987-05-07 Харьковский Автомобильно-Дорожный Институт Им.Комсомола Украины Способ приготовлени бетонной смеси
EP0206448B1 (fr) * 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hémoglobine liée à un poly(oxyde d'alkylène)
CA1275794C (fr) * 1986-02-28 1990-11-06 Christine Perry Produits d'addition de l'alcool propargylique et leur utilisation comme inhibiteurs de la corrosion dans des systemes d'acidification
US5229490A (en) 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
CA1322813C (fr) * 1987-06-01 1993-10-05 Edgar R. Wilson Compose azido a groupe azide terminal
US5080891A (en) 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
JPH0439327A (ja) * 1990-06-05 1992-02-10 Nippon Oil & Fats Co Ltd アジド末端アジ化ポリエーテル
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5595732A (en) * 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
US5191034A (en) * 1991-04-05 1993-03-02 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Branched energetic polyether elastomers
US5130381A (en) * 1991-04-05 1992-07-14 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government Branched energetic polyether elastomers
US5281698A (en) * 1991-07-23 1994-01-25 Cetus Oncology Corporation Preparation of an activated polymer ester for protein conjugation
US5226957A (en) * 1992-03-17 1993-07-13 Hewlett-Packard Company Solubilization of water-insoluble dyes via microemulsions for bleedless, non-threading, high print quality inks for thermal ink-jet printers
ATE156158T1 (de) 1992-04-14 1997-08-15 Cornell Res Foundation Inc Makromoleküle auf basis von dendritischen polymeren und verfahren zur herstellung
JP3465307B2 (ja) * 1993-08-05 2003-11-10 日本油脂株式会社 ポリアルキレンオキシド誘導体および製造方法
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
JPH07133156A (ja) * 1993-11-08 1995-05-23 Shin Etsu Chem Co Ltd 高純度窒化ケイ素粉末の鋳込み成形用スラリー組成物
US5446090A (en) 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
CA2136373A1 (fr) * 1993-11-29 1995-05-30 Steven W. Medina Glycols acetyleniques ethoxyles a faible tension superficielle dynamique
US5650234A (en) 1994-09-09 1997-07-22 Surface Engineering Technologies, Division Of Innerdyne, Inc. Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5534050A (en) * 1995-05-25 1996-07-09 Xerox Corporation Thermal ink jet composition
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
DE19532293A1 (de) * 1995-09-01 1997-03-06 Huels Chemische Werke Ag Anionische amphiphile Verbindungen mit mehreren hydrophilen und hydrophoben Gruppen auf der Basis von Acetylenderivaten
FR2743975B1 (fr) * 1996-01-22 1998-03-27 Baliozian Mardick Circuit electronique d'alimentation et de controle de ballast pour lampes d'eclairement
FR2753975B1 (fr) * 1996-10-02 1999-08-13 France Telecom Composes comportant des unites oxyeniques, leur procede de preparation et leur utilisation en electrochimie
US5998595A (en) 1996-11-05 1999-12-07 Wako Pure Chemical Industries, Ltd. Azidohalogenobenzyl derivatives, sugar compounds and protection of hydroxy groups
US6448369B1 (en) * 1997-11-06 2002-09-10 Shearwater Corporation Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
KR100297061B1 (ko) * 1998-03-30 2001-09-22 성재갑 폴리에톡실화 레틴아미드 유도체 및 그의 제조방법
AU2001238595A1 (en) * 2000-02-22 2001-09-03 Shearwater Corporation N-maleimidyl polymer derivatives
US6723785B2 (en) * 2000-07-17 2004-04-20 Kao Corporation Process for preparing aqueous dispersion of pigment-containing polymer particles
BR0004685B1 (pt) * 2000-10-05 2009-01-13 mÉtodo e dispositivo para estabilizaÇço da produÇço de poÇos de petràleo.
JP4386156B2 (ja) * 2001-05-30 2009-12-16 日信化学工業株式会社 水溶性界面活性剤組成物
US6828392B2 (en) * 2001-08-28 2004-12-07 Carlsberg A/S Hydroxy and amine functionalized resins
MXPA04004336A (es) 2001-11-07 2005-05-16 Nektar Therapeutics Al Corp Polimeros ramificados y sus conjugados.
US7235517B2 (en) * 2002-12-31 2007-06-26 3M Innovative Properties Company Degreasing compositions
SG143252A1 (en) * 2003-10-09 2008-06-27 Ambrx Inc Polymer derivatives

Also Published As

Publication number Publication date
WO2005035727A2 (fr) 2005-04-21
US20070123691A1 (en) 2007-05-31
EP1675620A2 (fr) 2006-07-05
WO2005035727A3 (fr) 2005-07-28
EP2322569A2 (fr) 2011-05-18
US7230068B2 (en) 2007-06-12
US7820766B2 (en) 2010-10-26
JP5681605B2 (ja) 2015-03-11
JP4890253B2 (ja) 2012-03-07
SG176455A1 (en) 2011-12-29
US9574048B2 (en) 2017-02-21
ES2831379T3 (es) 2021-06-08
US8008428B2 (en) 2011-08-30
US20050085619A1 (en) 2005-04-21
EP1675620B1 (fr) 2019-05-08
EP2322569A3 (fr) 2016-04-27
US20100217050A1 (en) 2010-08-26
JP2014208828A (ja) 2014-11-06
JP2007508427A (ja) 2007-04-05
ES2737837T3 (es) 2020-01-16
US20110269974A1 (en) 2011-11-03
JP2012031421A (ja) 2012-02-16
EP2322569B1 (fr) 2020-08-26
US20070123693A1 (en) 2007-05-31
US7737226B2 (en) 2010-06-15
EP1675620A4 (fr) 2006-12-27

Similar Documents

Publication Publication Date Title
SG143252A1 (en) Polymer derivatives
WO2003011115A3 (fr) Agents de contraste multimères ciblés à base de peptides
WO2002016412A3 (fr) Polypeptides de liaison pour proteine stimulatrice des lymphocytes b (blys)
AU2001272516A1 (en) Anti-slip protection device for a housing head for medical instruments
WO2001075067A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057188A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002022660A3 (fr) Noveaux acides nucleiques et polypeptides
WO2001066689A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002031111A3 (fr) Acides nucleiques et polypeptides
WO2001088088A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002059260A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002008285A3 (fr) Molecules il-17 et leurs utilisations
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
WO2001068859A3 (fr) Molecules du type recepteur de l'interleukine 17 et leur utilisation
WO2004087874A3 (fr) Acides nucleiques et polypeptides
WO1999067382A3 (fr) Sequences d'un facteur de croissance apparente a l'angiopoietine
WO2001072822A3 (fr) Genes impliques dans les maladies inflammatoires de l"intestin et leur utilisation
WO2004091368A3 (fr) Compositions d'argousier et methodes associees
WO2001049721A3 (fr) Nouveaux genes bacteriens et proteines qui sont essentielles pour la viabilite cellulaire et leurs utilisations
WO2003022868A3 (fr) Proteines pouvant se lier avec des metaux et procedes associes
WO2005018552A3 (fr) Proteines liant l'heparine : capteurs pour la detection de l'heparine
WO2005049806A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002044340A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001066752A3 (fr) Genes specifiques de la reproduction
WO2001059120A3 (fr) Molecules de type il-17 et utilisation de ces dernieres